These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19432575)

  • 1. Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):845-53. PubMed ID: 19432575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme.
    Herbert A; Anshu ; Culora G; Dunsmore H; Gupta SS; Holdsworth G; Kubba AA; McLean E; Sim J; Raju KS
    BJOG; 2010 May; 117(6):736-45. PubMed ID: 20184570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between the incidence of invasive cervical cancer and the screening interval: is a five year interval too long?
    Herbert A; Stein K; Bryant TN; Breen C; Old P
    J Med Screen; 1996; 3(3):140-5. PubMed ID: 8946309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the effect of occult invasive cancer on progress towards successful cervical screening.
    Herbert A; Bryant TN; Campbell MJ; Smith J
    J Med Screen; 1998; 5(2):92-8. PubMed ID: 9718528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: the yawning gap revisited and the treatment of risk.
    Herbert A; Smith JA
    Cytopathology; 1999 Jun; 10(3):161-70. PubMed ID: 10390064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
    Mitchell H; Medley G; Giles G
    BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
    Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
    Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers.
    Castanon A; Ferryman S; Patnick J; Sasieni P
    Cytopathology; 2012 Feb; 23(1):13-22. PubMed ID: 22243289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical screening: why young women should be encouraged to be screened.
    Herbert A; Holdsworth G; Kubba AA
    J Fam Plann Reprod Health Care; 2008 Jan; 34(1):21-5. PubMed ID: 18201402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
    Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
    Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.
    Elfström KM; Smelov V; Johansson AL; Eklund C; Nauclér P; Arnheim-Dahlström L; Dillner J
    BMJ; 2014 Jan; 348():g130. PubMed ID: 24435414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
    Tai YJ; Chen YY; Hsu HC; Chiang CJ; You SL; Chen CA; Cheng WF;
    J Gynecol Oncol; 2018 Jul; 29(4):e55. PubMed ID: 29770625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.
    Anttila A; Kotaniemi-Talonen L; Leinonen M; Hakama M; Laurila P; Tarkkanen J; Malila N; Nieminen P
    BMJ; 2010 Apr; 340():c1804. PubMed ID: 20423964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.
    Dillner J; Rebolj M; Birembaut P; Petry KU; Szarewski A; Munk C; de Sanjose S; Naucler P; Lloveras B; Kjaer S; Cuzick J; van Ballegooijen M; Clavel C; Iftner T;
    BMJ; 2008 Oct; 337():a1754. PubMed ID: 18852164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive cervical cancer in Southampton and South West Hampshire: effect of introducing a comprehensive screening programme.
    Herbert A; Breen C; Bryant TN; Hitchcock A; Macdonald H; Millward-Sadler GH; Smith J
    J Med Screen; 1996; 3(1):23-8. PubMed ID: 8861047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.